Buffalo Clinical Research Center Buffalo, NY - 14202

Buffalo Clinical Research Center is categorized under Commercial Research Laboratory in Buffalo, NY and active since 2000.

Buffalo Clinical Research Center was established in 2000, and today employs 1 to 4, earning Unknown per year. This is a Commercial Research Laboratory business, which does work in the B2B market, and is classified as a Commercial Research Laboratory, under code number 5417110 by the NAICS.

If you are seeking more information, feel free to contact Charles Ballow, Owner at the company’s single location by writing to 599 Delaware Avenue, Buffalo, New York NY 14202 or by phoning (716) 885-3580. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.

Business Name: Buffalo Clinical Research Center
Contact Person: Charles Ballow, Owner
Address: 599 Delaware Avenue, Buffalo, New York 14202
Phone Number: (716) 885-3580
Website Address: bcrc.us
Annual Revenue (USD): Unknown
Founded: 2000
Location Type: Single Location
Employee Number: 1 to 4
Business Type: B2B (Business to Business)
Business Category: Commercial Research Laboratory
SIC Code: 8731
NAICS Code: 5417110
Share This Business:

Buffalo Clinical Research Center was started in 2000 to provide professional Commercial Research Laboratory under the SIC code 8731 and NAICS code 5417110. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.

Feel free to contact Charles Ballow, Owner for inquiries that concern Buffalo Clinical Research Center by calling the company number (716) 885-3580, as your correspondence is most welcome. Additionally, the physical location of the single location of Buffalo Clinical Research Center can be found at the coordinates 42.90085,-78.87342 as well as the street address 599 Delaware Avenue in Buffalo, New York 14202.

For its online presence, you may visit Buffalo Clinical Research Center’s website at bcrc.us and engage with its social media outlets through on Twitter and on Facebook.